anesthesia and semaglutide Wegovy or Ozempic weight-loss drugs may raise anesthesia complication risks

💉 Ozempic and Wegovy are everywhere—but what do they mean for anesthesia providers? GLP-1 medications are changing the way clinicians think about aspiration risk, gastric emptying, and surgical preparation. In this episode,

27.47

★★★★☆4.8 (126)

Weight loss drugs linked to residual stomach content before anesthesia

20.51

★★★★★4.9 (98)

What happened in medicine this week has real consequences in the OR. 🔬 Swipe to see why: → Ozempic patients and surgery don't mix the way you might think → 30% of

20.38

★★★★★5.0 (157)

New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review

28.83

★★★★★4.7 (84)

PDF) Emerging Anesthesia Risks with Semaglutide

27.28

★★★★★4.9 (203)

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These

20.87

★★★★★5.0 (176)

What are the guidelines for general anesthesia in patients taking Glucagon-like peptide-1 (GLP1) receptor agonists, such as semaglutide (Ozempic) or liraglutide (Victoza), with a history of diabetes mellitus and potential impaired renal

28.96

★★★★★4.8 (132)